A client is taking an aminoglycoside antibiotic for pneumonia and will also be taking the loop diuretic furosemide (Lasix) due to fluid overload. The nurse will monitor carefully for which potential effect from the interaction of these two drugs?

Furosemide is a sulfonamide-derived loop diuretic that inhibits the Na+/K+/2Cl- symporter in the thick ascending limb of Henle. It facilitates profound diuresis and natriuresis to manage congestive heart failure and pulmonary edema by reducing intravascular volume. This drug frequently induces electrolyte depletion and metabolic disturbances, necessitating serum monitoring of potassium and magnesium levels. Adverse effects range from typical fluid shifts to life-threatening nephrotoxicity or ototoxicity if administered intravenously at rates exceeding 4 mg/min.

Rationale for correct answer

Common:

Hypokalemia. Renal excretion of potassium is an expected physiological consequence of increased sodium delivery to the distal tubule. This common effect requires dietary supplementation or pharmacological replacement to maintain serum levels between 3.5 and 5.0 mEq/L. It is a standard metabolic shift.

Hyperglycemia. Loop diuretics can interfere with pancreatic insulin release and diminish peripheral glucose utilization. This represents a common effect in patients with or without pre-existing diabetes mellitus. Nurses must monitor blood glucose levels periodically during long-term maintenance therapy.

Muscle cramps. Rapid loss of electrolytes, specifically potassium, magnesium, and calcium, leads to neuromuscular irritability. These common effects often occur during the initial phases of aggressive diuresis. They serve as a physical indicator of shifting fluid and ion balance.

Orthostatic hypotension. Significant reduction in circulating plasma volume diminishes the body's ability to maintain arterial pressure during postural changes. This common effect increases the risk of falls and syncope. Clients must be taught to move from supine positions slowly.

Hyperuricemia. Furosemide competes with uric acid for secretion in the proximal tubule, leading to increased serum concentrations. This is a common effect that may trigger acute gouty arthritis in susceptible individuals. It is a frequent biochemical byproduct of chronic loop diuretic use.

Dry mouth. Increased renal water clearance leads to systemic dehydration and decreased salivary secretion. This is a common effect and a subjective indicator of the drug's intended diuretic action. It reflects the overall volume depletion occurring within the extracellular compartment.

Severe:

Confusion. Alterations in mental status signal severe fluid-electrolyte imbalances or metabolic alkalosis affecting the central nervous system. This is a serious effect that requires immediate clinical intervention to prevent coma. It indicates profound cerebral dehydration or hyponatremia.

Tremors. Involuntary muscle contractions often result from severe hypomagnesemia or electrolyte derangements. This is a serious effect that can progress to tetany or cardiac arrhythmias if not addressed. It indicates a critical deficiency of essential divalent cations.

Test-taking strategy

• Categorize by severity: Distinguish between "nuisance" side effects that are predictable and "critical" changes that indicate organ dysfunction or life-threatening instability.
• Recall the "Hyper/Hypo" rules: Loop diuretics cause "hypo" states for most ions (potassium, sodium, magnesium) but "hyper" states for glucose and uric acid.
• Identify neurological triggers: Confusion and tremors are never "common" or expected; they indicate a neurological emergency secondary to severe electrolyte depletion.
• Link mechanism to symptoms:
  • Dehydration naturally causes dry mouth and orthostatic hypotension.
  • Electrolyte loss naturally causes muscle cramps.
• Evaluate metabolic impact: Hyperglycemia and hyperuricemia are standard metabolic disturbances associated with the loop of Henle's interaction with the proximal and distal tubules.
• Prioritize patient safety: Any symptom affecting consciousness or motor control (confusion/tremors) must be classified as serious.

Take home points

• Common adverse effects of furosemide involve predictable metabolic shifts like hypokalemia, hyperglycemia, and hyperuricemia.
• Hemodynamic changes, such as orthostatic hypotension and dry mouth, are expected results of the intended reduction in intravascular volume.
• Serious adverse effects like confusion and tremors indicate dangerous levels of dehydration or electrolyte depletion and require immediate medical assessment.
• Effective nursing care involves educating the client on both the expected minor discomforts and the critical symptoms that warrant an emergency call.

Spironolactone is a steroid-based aldosterone antagonist that competitively inhibits mineralocorticoid receptors in the distal renal tubules. This potassium-sparing diuretic prevents the reabsorption of sodium while inhibiting the active secretion of potassium and hydrogen ions. It effectively manages heart failure by mitigating the deleterious effects of hyperaldosteronism and cardiac remodeling. Side effects include gynecomastia, menstrual irregularities, and life-threatening electrolyte disturbances.

Rationale for correct answer

B. By antagonizing the mineralocorticoid receptor, spironolactone prevents the renal collecting duct from excreting potassium in exchange for sodium. This pharmacological mechanism leads directly to the retention of potassium, resulting in hyperkalemia (serum potassium > 5.0 mEq/L). This condition is the most dangerous metabolic complication of therapy. The nurse must monitor for cardiac dysrhythmias or peaked T-waves.

Rationale for incorrect answers

A. Loop and thiazide diuretics cause the loss of potassium, but spironolactone belongs to the potassium-sparing class which prevents such depletion. Consequently, hypokalemia is not a characteristic adverse effect of this specific medication. Patients are actually instructed to avoid high-potassium diets. This prevents the risk of myocardial instability associated with low potassium.

C. Spironolactone does not interfere with pancreatic insulin secretion or hepatic gluconeogenesis pathways to cause a drop in blood sugar. While some diuretics impact glucose, hypoglycemia is not a documented or expected side effect of aldosterone antagonists. The drug primarily influences electrolyte homeostasis rather than carbohydrate metabolism. Diabetic monitoring focuses more on potassium-induced insulin shifts.

D. Although diuretics can occasionally influence secondary mineral levels, spironolactone is not a primary cause of significant hypermagnesemia. Excessive magnesium levels ( > 2.2 mEq/L) are typically associated with renal failure or antacid overuse. The clinical priority for this drug remains the potassium balance. Magnesium shifts are rarely the primary clinical concern during standard dosing.

Test-taking strategy

• Identify the drug class: Categorize spironolactone as a potassium-sparing diuretic.
• Recall the physiological trade-off:
  • Normal aldosterone causes the body to keep sodium and lose potassium.
  • An aldosterone antagonist does the opposite: it loses sodium and keeps potassium.
• Evaluate the suffix/prefix: Recognize the "one" suffix often denotes a steroid-related structure, which in this case competes with the steroid hormone aldosterone.
• Match the mechanism to the risk: If the body is "sparing" or keeping potassium, the primary risk must be an excess of that ion.
• Differentiate from other diuretics: Contrast this with "potassium-wasting" diuretics like furosemide (loop) or hydrochlorothiazide (thiazide).
• Select the high-acuity answer: Hyperkalemia (Option 2) is the most common and life-threatening risk associated with this specific drug's mechanism of action.

Take home points

• Spironolactone is used in heart failure to block the effects of aldosterone, which helps prevent myocardial fibrosis and sodium retention.
• The most critical nursing priority is monitoring for hyperkalemia, especially in patients with impaired renal function or those taking ACE inhibitors.
• Patients should be educated to avoid salt substitutes containing potassium chloride, as these can cause lethal increases in serum potassium.
• Endocrine side effects such as gynecomastia or breast tenderness may occur because spironolactone can also bind to androgen and progesterone receptors.